Free Trial

Luisa Hector Analyst Performance

Analyst at Berenberg Bank

Luisa Hector is a stock analyst at Berenberg Bank in the medical sector, covering 4 publicly traded companies. Over the past year, Luisa Hector has issued 3 stock ratings, including buy and hold recommendations. While full access to Luisa Hector's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luisa Hector's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 3 Years
Buy Recommendations
50.00% 1 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%1 ratings
Hold50.0%1 ratings
Sell0.0%0 ratings

Out of 2 total stock ratings issued by Luisa Hector at Berenberg Bank, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
75.0% of companies on NYSE
3 companies
NASDAQ
25.0% of companies on NASDAQ
1 company

Luisa Hector, an analyst at Berenberg Bank, currently covers 4 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
100.0%

Luisa Hector of Berenberg Bank specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
LARGE CAP PHARMA
3 companies
75.0%
MED - BIOMED/GENE
1 company
25.0%

Luisa Hector's Ratings History at Berenberg Bank

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
AbbVie Inc. stock logo
ABBV
AbbVie
9/17/2025Upgrade$216.27$270.00Buy
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
9/17/2025Downgrade$81.07$90.00Hold
AstraZeneca PLC stock logo
AZN
AstraZeneca
7/9/2025Set Price Target$70.80$97.00